SCM
Suvretta Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.8M | Buy |
2,878,000
+1,231,385
| +75% | +$21.3M | 1.5% | 21 |
|
|
2025
Q1 | $36M | Buy |
1,646,615
+853,428
| +108% | +$18.7M | 1.34% | 23 |
|
|
2024
Q4 | $25.3M | Buy |
+793,187
| New | +$25.3M | 0.86% | 37 |
|
|
2020
Q2 | – | Sell |
-21,600
| Closed | -$579K | – | 80 |
|
|
2020
Q1 | $579K | Buy |
+21,600
| New | +$579K | 0.02% | 59 |
|